IBT B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Infant Bacterial Therapeutics is a biotechnology company focused on developing innovative treatments for inflammatory bowel diseases. The company develops, among other things, medicines to treat and prevent common conditions and diseases in children that occur at early birth. The business is global with a primary presence in Europe and North America. Infant Bacterial Therapeutics was founded in 2011 and is headquartered in Stockholm, Sweden.
Read moreEPS (adj.)
Dividend %
Interim report Q3'26
Annual report '26
Interim report Q1'27
Don't miss out - create an account and get all the possible benefits